Tìm kiếm
Đang tải khung tìm kiếm
Kết quả 1 đến 1 của 1

    THẠC SĨ Microsomal epoxide hydrolase gene is a novel endogenous protectant against beta

    dream dream Đang Ngoại tuyến (18524 tài liệu)
    .:: Cộng Tác Viên ::.
  1. Gửi tài liệu
  2. Bình luận
  3. Chia sẻ
  4. Thông tin
  5. Công cụ
  6. Microsomal epoxide hydrolase gene is a novel endogenous protectant against beta

    Microsomal epoxide hydrolase gene is a
    novel endogenous protectant against beta
    amyloid (1-42)-induced cognitive
    impairments in mice
    Ngo Thi Ngoc Yen
    Department of Pharmacy
    Graduate School, Kangwon National University
    Microsomal epoxide hydrolase (mEH) is one of critical
    biotransformation enzymes in xenobiotic metabolism and
    detoxification. In the early study, it was suggested that mEH may play a
    modulatory role in pathogenesis of neurodegeneration in response to
    environmental stress. To extend this understanding, the role of mEH in
    the β amyloid (βA)-induced memory impairment was examined by
    using mEH (-/-) mice and wild-type mice (WT). The cognitive
    performance was assessed using Morris water maze, passive avoidance,
    Y maze, novel object recognition test and water finding test after
    intracerebroventricular (i.c.v) injection with βA (1-42). The result

    showed that functional deficits of learning and memory in mEH (-/-)
    groups were significant impaired compared to the WT. Decreases in the
    acetylcholine (ACh) and choline acetyltransferase (ChAT) activity and
    its expresstion, while increases in the acetylcholinesterase activity and
    its expression were observed in the hippocampus of mEH (-/-) mice.
    Consistently, effects of cyclohexene-oxide (CHO), a mEH inhibitor
    were comparable to mEH (-/-) case. In addition, ChAT expression was
    observed lower and AChE expression was higher in the APPswe/PS1
    double transgenic mice. Unexpectedly, a significant increase in mEH
    expression in the APPswe/PS1 double transgenic mice was observed in
    the hippocampus and entorhinal cortex reflecting that compensative
    induction of mEH to modulate of APPswe/PS1 gene. Combined, these
    data suggests that mEH plays a neuroprotective role against cognitive
    dysfunction induced by βA.


    I. Introduction 1
    II. Material and methods 4
    III. Results . 13
    IV. Discussion 31
    V. References . 36

    List of figures

    Fig. 1. Experimental schedule for measuring Aβ (1-42)-induced
    cognitive impairment in the mEH (+/+)-, CHO-treated mEH (+/+)-, and
    mEH (-/-)-mice. . 18
    Fig. 2. Effects of mEH gene deficiency and CHO (100mg/kg, i.p.) on
    the water maze performance [hidden platform performance (A), probe
    performance (B), and working memory performance (C)] after Aβ (1-42)
    infusion. . 20
    Fig. 3. Effects of mEH gene deficiency and CHO (100mg/kg, i.p.) on
    the Y-maze performance (A) and novel object recognition performance
    (B after Aβ (1-42) infusion. . 21
    Fig. 4. Effects of mEH gene deficiency and CHO (100mg/kg, i.p.) on
    the water finding performance (A) and passive avoidance performance
    (B) after Aβ (1-42) infusion. 22
    Fig. 5. Effects of mEH gene deficiency and CHO (100mg/kg, i.p.) on
    the ACh level (A), activities of AChE (B) and ChAT (C) in the
    hippocampus of mice after Aβ (1-42) infusion 23
    Fig. 6. Effects of mEH gene deficiency on the gene expressions of
    AchE (A) and ChAT (B) in the hippocampus of mice after Aβ (1-42)
    infusion 24
    Fig. 7. AchE expression in the hippocampus of mEH (+/+)-, and mEH
    (-/-)-mice 25
    Fig. 8. ChAT expression in the hippocampus of mEH (+/+)-, and mEH
    (-/-)-mice 26
    Fig. 9. AchE expression in the hippocampus of APPswe/PS1dE9 wild-

    type and APPswe/PS1dE9 double transgenic mice . 27
    Fig. 10. ChAT expression in the hippocampus of APPswe/PS1dE9 wild-
    type and APPswe/PS1dE9 double transgenic mice . 28
    Fig. 11. mEH expression in the hippocampus of APPswe/PS1dE9 wild-
    type and APPswe/PS1dE9 double transgenic mice 29
    Fig. 12. Flow chart describing current hypothesis on the roles of mEH
    gene in the Aβ (1-42)-induced memory dysfunction . 301

    I. Introduction
    Alzheimer's disease (AD) results from neurodegeneration characterized by
    the deposition of senile plaques, development of neurofibrillary tangles,
    inflammation, and neuronal loss. The senile places are composed of amyloid β-
    peptide (Aβ), a 40-42 amino acid peptide fragment of the β-amyloid precursor
    protein that plays an important role in the development of AD. It has been
    demonstrated that a continuous intracerebroventricular (i.c.v) infusion of Aβ (1-42)
    into the cerebral ventricle in rats results in learning and memory deficit (Estrin et
    al., 1987a; Nitta et al., 1994). We have demonstrated that a single i.c.v. injection of
    Aβ (1-42) causes the memory deficits in mice (Crystal et al., 1988; Jhoo et al.,
    2004; Estrin et al., 1990).
    It has been demonstrated that cholinergic system may play a crucial role in
    modulating cognitive performance and learning memory processes (Winkler et al.,
    1995) and deterioration of acetylcholine (ACh) function contribute to cognitive
    decline, which might be associated with AD (Mesulam MM., 1996). Moreover, in
    addition to significant neuronal cell loss within this brain region, evidence
    implicating the basal forebrain cholinergic system in AD neuropathology comes
    from numerous studies demonstrating decreases in choline acetyltransferase
    (ChAT) activity (Bowen et al., 1976; Davies and Maloney, 1976; Perry et al., 1977;
    Whitehouse et al., 1982), high affinity choline uptake (Rylett et al., 1983),
    acetylcholine (ACh) release (Nilsson et al., 1986), and both nicotinic and
    muscarinic ACh receptor binding (Araujo et al., 1988) in post-mortem brain tissue
    of AD patients compared to non-pathological control brains. These evidences 2

    implicate basal cholinergic system involvement in AD pathogenesis and its
    accompanying cognitive deficits.
    Microsomal epoxide hydrolase (mEH), a member of epoxide hydrolase (EH;
    EC3.3.2.3) family, is one of several xenobiotic biotransformation enzymes. mEH
    catalyzes the trans-addition of water to a broad range of epoxide subtracts (Fretland
    and Omiecinski, 2000). mEH appears to have universal expression in all tissues
    studies to date include the brain. mEH is thought to play a pivotal role in protection
    against the toxicity of reactive epoxide intermediates, because metabolism of
    epoxides by this enzyme results in the production of less reactive and less toxic
    dihyrodiol intermediates of drug such as phenytoin and carbamazepine (Gaedigk et
    al., 1994 ). Futhermore, mEH is involved in metabolism of compound-containing
    epoxide induced cognitive impairment (Brashear et al., 1996; Estrin et al., 1987a;
    Fennell and Brown, 2001). In contrast to this protective effect, it was suggested
    that mEH is required for the metabolic activation of the potent carcinogen 7, 12-
    dimethylbenz[a]anthracene (DMBA), a widely studied experimental prototype for
    the polycylic aromatic hydrocarbon class of chemical carcinogens (Miyata et al.,
    1999). We hypothesized that the induction of mEH in the striatal complex after
    drug dependence is a compensative/protective response to low dose of
    methamphetamine (Shin et al., 2009). However, mEH is involved in the MPTP-
    induced doparminergic toxicology (Liu et al., 2008). Importantly, we reported an
    increase in mEH expression in the hippocampus and the entorhinal and
    transentorhinal cortex of AD cases, where severe pathology is usually found. mEH
    colocalized with astrocytes but did not colocalize with amyloid plaques (Liu et al.,
    2006). As a result, mEH remains to be charaterised whether mEH has an important
    role in neuroprotection or neurodegeneration in response to environmental stress. 3

    To achieve better understandings, we examined the role of mEH using
    mEH (-/-) mice with mEH inhibitor-cyclohexene oxide (CHO) in the presence of
    Aβ (1-42) exposure. In addition, we examined mEH expression in the
    APPswe/PS1dE9 double transgenic mice. It was assessed Aβ (1-42)-induced
    behavioral changes, ACh level, AChE and ChAT activity and their expressions in
    the mEH (+/+)-, and mEH (-/-)-mice. This study suggested that mEH gene plays an
    essential role to maintain cognitive function in the presence of Aβ (1-42)-induced
    cognitive impairment.

    II. Materials and methods
    2.1. Animals and Drug treatments
    All mice were treated in strict accordance with the NIH Guide for the
    Humane Care and Use of Laboratory Animals. Male six month-old mEH (-/-)-mice
    and male ten month-old APP/PS2dE9 double transgenic mice [B6C3-Tg (APPswe,
    PSEN1De9) 85Dbo/J] were maintained on a 12:12 h light: dark cycle and fed ad
    libitum. Also, they were adapted to these conditions for 2 weeks before the
    Aβ (42-1) and Aβ (1-42) were dissolved in 35% acetonitrile containing
    0.1% trifluoroacetic acid. The Aβ (42-1) or Aβ (1-42) administration [400 pmol,
    intracerebroventricular injection (i.c.v.)] was performed according to the procedure
    established by Laursen and Belkap (Laursen and Belknap, 1986). Briefly, each
    mouse was injected consciously at bregma with a 10 àl Hamilton microsyringe
    fitted with a 26-gauge needle that was inserted to a depth of 2.4 mm. The injection
    volume was 1.8 àl. The injection placement or needle track was visible and was
    verified at the time of dissection.
    CHO (100mg.kg, i.p) was dissolve in saline and administered to Aβ treated
    mice for 11 consecutive days. The experimental schedule is shown in Fig. 1. CHO
    or saline administration began 1 h before Aβ i.c.v injection and behavioral test. The
    behavioral study began on day 3 after Aβ i.c.v. infusion, and carried out
    sequentially. All mice were sacrificed immediately after behavioral tests. For
    histological analysis, animals were anesthetized with 60% urethane and perfuse 5

    transcardially with 200 ml of 50 mM phosphate buffered saline (PBS), followed by
    50 ml of paraformaldehyde in PBS. The brains were fixed at 4
    C for 24 h in the
    same fixative and then cryoprotected in 30% sucrose. The brains were sectioned on
    a horizontal sliding microstome into 35 àm transverse free-floading sections. For
    western blot analysis and biochemical assay, the brains were quickly removed, the
    hippocampus tissues were dissected out and samples were instantly frozen in liquid
    nitrogen and kept at -79
    C until needed for analysis.
    2.2. Morris water test
    The apparatus was circular water, 97 cm in diameter and 60 cm height.
    During testing, the tank was filled with water (23 ± 2 °C) that was clouded with
    powered milk. A transparent platform was set inside the tank and its top was
    submerged 2 cm below the water surface in the center of one among the four
    quadrants of the maze. The tank was located in a large room with many extramaze
    cues that were constant throughout the study (Morris, 1984). The movements of the
    animal in the tank were monitored with a video tracking system (EthoVision,
    Noldus, The Netherlands).
    2.2.1. Reference memory test
    For each training trial, the mouse was put into the pool at one of the five
    positions, the sequence of the positions being selected randomly. The platform was
    located a constant position throughout the test period in the middle of one quadrant,
    equidistant from the center and edge of the pool. In each training session, the
    latency to escape on to the hidden platform was recorded. If the mouse found the
    platform, it was allowed to remain there for 10 s and was then returned to its home
    cage. If the mouse was unable to find the platform within 60 s, the training was 6

    terminated and a maximum score of 60 s was assigned. Training was conducted for
    four consecutive days, four times a day, from day 3 to 6 after the Aβ i.c.v. injection.
    2.2.2. Probe test
    On day 7 after Aβ i.c.v. injection, a double probe trial was conducted. The
    platform was removed from the pool and each mouse was allowed to swim for 60 s
    in the maze. The time spent by the animal searching for the missing platform on the
    target quadrant was recorded.
    2.2.3. Working memory (repeated acquisition) test
    Working memory test was conducted three consecutive days from day 8 to
    10 and consisted of five trials per day. The working memory test was procedurally
    similar to reference memory test except that the platform location was changed
    daily. The first trial of the day was an informative sample trial in which the mouse
    was allowed to swim to the platform in its new location. Spatial working memory
    was regarded as the mean escape latency of the second to fifth trials.
    2.3. Y-maze test
    The Y-maze was carried out on day 3 after Aβ (1-42) injection as described
    previously (Maurice et al., 1994). Briefly, the maze was made of black painted
    wood; each arm was 40 cm long, 12 cm high, 3 cm wide at the bottom and 10 cm
    wide at the top. The arms converged at an equilateral triangular central area that
    was 4 cm at its longest axis. Each mouse was placed at the end of one arm and
    allowed to move freely through the maze during an 8 min session. The series of
    arm entries were recorded visually. Alternation was defined as successive entry
    into the three arms, on overlapping triplet sets. The alternation percentage was 7

    calculated as the ratio of actual alternations to possible alternations (defined as the
    total number of arm entries minus 2), multiplied by 100.
    2.4. Novel object recognition test
    This task, based on the spontaneous tendency of rodents to explore a novel
    object more often than a familiar one (Ennaceur and Delacour, 1988) was
    performed with a slight modification as described previously (Dodart et al., 2002).
    A plastic chamber (35 cm×35 cm×35 cm) was used in low light condition during
    the light phase of the light/dark cycle. The general procedure consisted of three
    different phases: a habituation phase, an acquisition phase, and a retention phase.
    On the 1st day (habituation phase), mice were individually subjected to a single
    familiarization session of 10 min, during which they were introduced in the empty
    arena, in order to become familiar with the apparatus. On the 2nd day (acquisition
    phase) animals were subjected to a single 10 min session, during which floor-fixed
    two objects (A and B) were placed in a symmetric position from the center of the
    arena, 15 cm from each and 8 cm from the nearest wall. The two objects, made of
    the same wooden material with the similar color and smell, were different in shape
    but identical in size. Mice were allowed to explore the objects in the open field. A
    preference index for each mouse was expressed as a ratio of the amount of time
    spent exploring object A (TA ×100)/(TA + TB), where TA and TB are the time
    spent on exploring object A and object B, respectively. On the 3rd day (retention
    phase), mice were allowed to explore the open field in the presence of two objects:
    the familiar object A and a novel object C in different shape but in similar color
    and size (A and C). A recognition index, calculated for each mouse, was expressed
    as the ratio (TC ×100)/(TA + TC), where TA and TC are the time spent during
    retention phase on object A and object C, respectively. The time spent exploring

    Xem Thêm: Microsomal epoxide hydrolase gene is a novel endogenous protectant against beta
    Nội dung trên chỉ thể hiện một phần hoặc nhiều phần trích dẫn. Để có thể xem đầy đủ, chi tiết và đúng định dạng tài liệu, bạn vui lòng tải tài liệu. Hy vọng tài liệu Microsomal epoxide hydrolase gene is a novel endogenous protectant against beta sẽ giúp ích cho bạn.
  7. Đang tải dữ liệu...

    Chia sẻ link hay nhận ngay tiền thưởng
    Vui lòng Tải xuống để xem tài liệu đầy đủ.

    Gửi bình luận

    ♥ Tải tài liệu

social Thư Viện Tài Liệu
Tài liệu mới

Từ khóa được tìm kiếm

Nobody landed on this page from a search engine, yet!

Quyền viết bài

  • Bạn Không thể gửi Chủ đề mới
  • Bạn Không thể Gửi trả lời
  • Bạn Không thể Gửi file đính kèm
  • Bạn Không thể Sửa bài viết của mình
DMCA.com Protection Status